- Home
- CREG vs INM Comparison
CREG vs INM Comparison
Compare CREG & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREG
- INM
- Stock Information
- Founded
- CREG N/A
- INM 1981
- Country
- CREG China
- INM Canada
- Employees
- CREG N/A
- INM N/A
- Industry
- CREG Power Generation
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- CREG Utilities
- INM Health Care
- Exchange
- CREG Nasdaq
- INM Nasdaq
- Market Cap
- CREG 4.3M
- INM 5.0M
- IPO Year
- CREG N/A
- INM N/A
- Fundamental
- Price
- CREG $1.25
- INM $2.15
- Analyst Decision
- CREG
- INM
- Analyst Count
- CREG 0
- INM 0
- Target Price
- CREG N/A
- INM N/A
- AVG Volume (30 Days)
- CREG 393.2K
- INM 120.8K
- Earning Date
- CREG 11-07-2025
- INM 11-13-2025
- Dividend Yield
- CREG N/A
- INM N/A
- EPS Growth
- CREG N/A
- INM N/A
- EPS
- CREG N/A
- INM N/A
- Revenue
- CREG $82,839.00
- INM $4,942,633.00
- Revenue This Year
- CREG N/A
- INM N/A
- Revenue Next Year
- CREG N/A
- INM N/A
- P/E Ratio
- CREG N/A
- INM N/A
- Revenue Growth
- CREG N/A
- INM 7.50
- 52 Week Low
- CREG $1.02
- INM $1.72
- 52 Week High
- CREG $14.70
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- CREG 46.05
- INM 45.46
- Support Level
- CREG $1.31
- INM $2.04
- Resistance Level
- CREG $1.55
- INM $2.26
- Average True Range (ATR)
- CREG 0.14
- INM 0.14
- MACD
- CREG -0.02
- INM -0.01
- Stochastic Oscillator
- CREG 39.02
- INM 21.74
About CREG Smart Powerr Corp.
Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.